Vector construction

MN Maria Lund Nielsen
TI Thomas Isbrandt
KR Kasper Bøwig Rasmussen
UT Ulf Thrane
JH Jakob Blæsbjerg Hoof
TL Thomas Ostenfeld Larsen
UM Uffe Hasbro Mortensen
request Request a Protocol
ask Ask a question
Favorite

PCR fragments were amplified using the PfuX7 polymerase [21] with primers purchased from Integrated DNA Technology, Belgium (S1 Table). Construction of vectors was carried out by Uracil-Specific Excision Reagent (USER) fusion of PCR fragment into compatible plasmids [22]. The deletion plasmids pD-hyg-talA and pD-hyg-albA were constructed by amplification of approximately 2-kb up- and downstream fragments followed by cloning into two distinct PacI/Nt.BbvCI USER cassettes located on each side of the hygromycin resistance gene. The sgRNA was introduced into the CRISPR-Cas9 vector pFC330 via the tails of two primers as described by Nødvig et al. [4]. Plasmids were purified using the GenEluteTM Plasmid Miniprep Kit (Sigma-Aldrich), and verified by restriction analysis. A list of all plasmids from this study is presented in S2 Table. Deletions were achieved using the CRISPR-Cas9 system described by Nødvig et al. [4]. A circular deletion plasmid (gene-targeting substrate) was co-transformed with an AMA1-based CRISPR-Cas9 vector containing the guide RNA and the Streptococcus pyogenes cas9 gene codon optimized for A. niger. The CRISPR-Cas9 vector also contained the pyrG auxotrophic marker; however, only the deletion plasmid, containing the hygromycin resistance gene, was selected for during transformation.

Do you have any questions about this protocol?

Post your question to gather feedback from the community. We will also invite the authors of this article to respond.

post Post a Question
0 Q&A